E P Davidson
Overview
Explore the profile of E P Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oltman C, Davidson E, Coppey L, Kleinschmidt T, Yorek M
Diabetes Obes Metab
. 2008 Jun;
11(3):223-33.
PMID: 18564175
Aim: Vasopeptidase inhibitors are drugs that inhibit angiotensin-converting enzyme and neutral endopeptidase (NEP). The latter is a protease that degrades vasoactive peptides and is increased in diabetes. We have previously...
2.
Oltman C, Davidson E, Coppey L, Kleinschmidt T, Lund D, Adebara E, et al.
Diabetes Obes Metab
. 2007 Nov;
10(1):64-74.
PMID: 17970755
Aim: We had previously demonstrated that vascular and neural dysfunction in Zucker diabetic fatty (ZDF) rats is progressive. In this study, we sought to determine whether monotherapy of ZDF rats...
3.
Yorek M, Coppey L, Gellett J, Davidson E
Exp Diabesity Res
. 2004 Oct;
5(3):187-93.
PMID: 15512786
The authors have determined that epineurial arterioles of the sciatic nerve are innervated by nonadrenergic, noncholinergic nerves that contribute to the regulation of vasodilation. Using immunohistochemistry, the authors determined that...
4.
Yorek M, Coppey L, Gellett J, Davidson E, Lund D
Exp Diabesity Res
. 2004 Jun;
5(2):123-35.
PMID: 15203883
In the present study, the authors examined whether treating streptozotocin-induced diabetic rats with the combination of alpha-lipoic acid and fidarestat, an aldose reductase inhibitor, can promote the formation of dihydrolipoic...
5.
Coppey L, Gellett J, Davidson E, Dunlap J, Lund D, Salvemini D, et al.
Br J Pharmacol
. 2001 Aug;
134(1):21-9.
PMID: 11522593
1. To further explore the effect of antioxidants in preventing diabetes-induced vascular and neural dysfunction we treated streptozotocin-induced diabetic rats daily with subcutaneous injections of 10 mg kg(-1) of M40403...
6.
Coppey L, Gellett J, Davidson E, Dunlap J, Lund D, Yorek M
Diabetes
. 2001 Jul;
50(8):1927-37.
PMID: 11473057
We have shown that diabetes-induced reduction in endoneurial blood flow (EBF) and impaired endothelium-dependent vascular relaxation precede slowing of motor nerve conduction velocity (MNCV) and decreased sciatic nerve Na(+)/K(+) ATPase...
7.
Coppey L, Davidson E, Dunlap J, Lund D, Yorek M
Int J Exp Diabetes Res
. 2001 Jul;
1(2):131-43.
PMID: 11469397
Diabetes mellitus produces marked abnormalities in motor nerve conduction, but the mechanism is not clear. In the present study we hypothesized that in the streptozotocin (STZ)-induced diabetic rat impaired vasodilator...
8.
Terata K, Coppey L, Davidson E, Dunlap J, Gutterman D, Yorek M
Br J Pharmacol
. 1999 Oct;
128(3):837-43.
PMID: 10516670
1. Diabetes mellitus produces marked abnormalities in motor nerve conduction, but the mechanism is not clear. In the present study we hypothesized that in the streptozotocin (STZ)-induced diabetic rat impaired...
9.
Sima A, Dunlap J, Davidson E, Wiese T, Lightle R, Greene D, et al.
Diabetes
. 1997 Feb;
46(2):301-6.
PMID: 9000708
Nerve myo-inositol depletion, which has been implicated in the pathogenesis of acute experimental diabetic neuropathy, can be reproduced in normal rats by feeding diets enriched in L-fucose, a competitive inhibitor...
10.
Yorek M, Wiese T, Davidson E, Dunlap J, CONNER C
Metabolism
. 1996 Feb;
45(2):229-34.
PMID: 8596495
Development of early defects in diabetic neuropathy has been linked to metabolic abnormalities and is considered reversible. To further address some of the questions concerning the contribution by metabolic derangements...